Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
TiumBio Announces First Patient Dosed in Phase 2 Clinical Trial of Oral Immuno-Oncology Drug TU2218 2024-10-04 20:00
WELLlife COVID-19/Influenza A&B Home Test on Sale for Amazon Prime Day 2024-10-03 21:00
The Exosome Production Method Patent by Panacell Biotech Registered as Original Technology 2024-10-03 20:00
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika 2024-10-02 20:00
Zepp Regains Compliance with NYSE Minimum Price Continued Listing Criterion 2024-10-02 19:00
Baird Medical and ExcelFin Acquisition Corp Complete Business Combination 2024-10-02 05:37
PeptiGrowth Inc. is Launching a Novel Synthetic FGF2 Alternative Peptide (FGFR1c Agonist) 2024-10-01 21:00
Digital & Intelligent Pathway: Xiaohongshu and VOGUE Business Unveil Groundbreaking Lifestyle Marketing Insights at Milan Summit 2024-09-30 16:50
Xiaohongshu x VOGUE Business Unveils New Horizons in Healthcare and Wellness at Milan Summit 2024-09-30 16:30
NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics 2024-09-30 15:51
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Severe Hypertriglyceridemia 2024-09-30 15:00
IASO Bio Scientist and Leading Chinese Physicians in Onco-Hematology Visit Hematology Center at the State University of Campinas, Brazil, to Explore Cooperation in Cancer Treatment 2024-09-30 13:48
Akeso's Cadonilimab Receives Second Indication Approval from NMPA for First-Line Treatment of Gastric/GEJ Cancer in All-Comers Population 2024-09-30 13:42
World's First Carbon Neutral Salad: The Revolutionary Drinkable Salad that's Good for You and the Planet 2024-09-30 13:22
Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of next-generation CDK inhibitors for the Treatment of Breast Cancer 2024-09-30 13:00
IASO Bio Presented Comparative Clinical Outcomes on the Optimal Lymphodepletion Prior to Infution of Equecabtagene Autoleucel（FucasoTM）in Patients with Relapsed Refractory Multiple Myeloma at 2024 IMS Annual Meeting 2024-09-29 21:00
SeromYx Systems and ACROBiosystems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies 2024-09-29 21:00
New Beginnings, New Journey | Sanyou Opening of New 10,000-sqm Facility, Ushering in a New Era of Innovation for Bio Drugs 2024-09-28 20:00
111, Inc. Announces Receipt of Notification from Nasdaq 2024-09-28 05:00
Ping An Healthcare and Technology Stock Soared 10% - Managed Care Takes Center Stage in Corporate Health Management 2024-09-27 21:12
1 10 11 12 13 14 800